Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weichselbaum

Showing results (311-320 of 816) with videos related to

Pageof 82
Sort By:
Journal of the National Cancer Institute|October 2, 2015
Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung CancerMatthew Koshy, Renuka Malik, Usama Mahmood, et al.
Cancer Research|August 1, 1995
Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiationT D Shafman, A Saleem, J Kyriakis, et al.
Cancer Research|August 15, 1993
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell linesD G Brachman, M Beckett, D Graves, et al.
Journal of the National Cancer Institute|December 4, 1996
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancerR Heimann, D Ferguson, C Powers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Statin use and risk of prostate cancer recurrence in men treated with radiation therapyRuchika Gutt, Nathan Tonlaar, Rangesh Kunnavakkam, et al.
The Journal of Biological Chemistry|June 14, 2000
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatinA Bhattacharyya, U S Ear, B H Koller, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostineYasushi Kataoka, Jeffrey S Murley, Nikolai N Khodarev, et al.
Nucleic Acids Research|November 10, 2000
Quantitative analysis of DNA array autoradiographsC A Pelizzari, N N Khodarev, N Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1982
Radiation therapy in the management of patients with mesotheliomaW Gordon, K H Antman, J S Greenberger, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1982
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancerR R Weichselbaum, M R Posner, T J Ervin, et al.
Pageof 82

Showing results (311-320 of 816) with videos related to

Sort By:
Pageof 82
Journal of the National Cancer Institute|October 2, 2015
Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung CancerMatthew Koshy, Renuka Malik, Usama Mahmood, et al.
Cancer Research|August 1, 1995
Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiationT D Shafman, A Saleem, J Kyriakis, et al.
Cancer Research|August 15, 1993
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell linesD G Brachman, M Beckett, D Graves, et al.
Journal of the National Cancer Institute|December 4, 1996
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancerR Heimann, D Ferguson, C Powers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Statin use and risk of prostate cancer recurrence in men treated with radiation therapyRuchika Gutt, Nathan Tonlaar, Rangesh Kunnavakkam, et al.
The Journal of Biological Chemistry|June 14, 2000
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatinA Bhattacharyya, U S Ear, B H Koller, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostineYasushi Kataoka, Jeffrey S Murley, Nikolai N Khodarev, et al.
Nucleic Acids Research|November 10, 2000
Quantitative analysis of DNA array autoradiographsC A Pelizzari, N N Khodarev, N Gupta, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1982
Radiation therapy in the management of patients with mesotheliomaW Gordon, K H Antman, J S Greenberger, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1982
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancerR R Weichselbaum, M R Posner, T J Ervin, et al.
Pageof 82